Viewing Study NCT03850366


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2025-12-25 @ 6:33 PM
Study NCT ID: NCT03850366
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2019-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Sponsor: Henry Ford Health System
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module